These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16827563)

  • 1. Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.
    Boldt GE; Kennedy JP; Hixon MS; McAllister LA; Barbieri JT; Tzipori S; Janda KD
    J Comb Chem; 2006; 8(4):513-21. PubMed ID: 16827563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
    Teng YH; Berger WT; Nesbitt NM; Kumar K; Balius TE; Rizzo RC; Tonge PJ; Ojima I; Swaminathan S
    Bioorg Med Chem; 2015 Sep; 23(17):5489-95. PubMed ID: 26275678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry.
    Boldt GE; Kennedy JP; Janda KD
    Org Lett; 2006 Apr; 8(8):1729-32. PubMed ID: 16597152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.
    Šilhár P; Alakurtti S; Čapková K; Xiaochuan F; Shoemaker CB; Yli-Kauhaluoma J; Janda KD
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2229-31. PubMed ID: 21421315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.
    Li B; Cardinale SC; Butler MM; Pai R; Nuss JE; Peet NP; Bavari S; Bowlin TL
    Bioorg Med Chem; 2011 Dec; 19(24):7338-48. PubMed ID: 22082667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Hydroxyquinoline and hydroxamic acid inhibitors of botulinum neurotoxin BoNT/A.
    Dickerson TJ; Smith GR; Pelletier JC; Reitz AB
    Curr Top Med Chem; 2014; 14(18):2094-102. PubMed ID: 25335884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease.
    Stowe GN; Silhár P; Hixon MS; Silvaggi NR; Allen KN; Moe ST; Jacobson AR; Barbieri JT; Janda KD
    Org Lett; 2010 Feb; 12(4):756-9. PubMed ID: 20092262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.
    Jacobson AR; Adler M; Silvaggi NR; Allen KN; Smith GM; Fredenburg RA; Stein RL; Park JB; Feng X; Shoemaker CB; Deshpande SS; Goodnough MC; Malizio CJ; Johnson EA; Pellett S; Tepp WH; Tzipori S
    Toxicon; 2017 Oct; 137():36-47. PubMed ID: 28698055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hinge peptide combinatorial libraries for inhilbitors of botulinum neurotoxins and saxitoxin: deconvolution strategy.
    Moore GJ; Moore DM; Roy SS; Hayden LJ; Hamilton MG; Chan NW; Lee WE
    Mol Divers; 2006 Feb; 10(1):9-16. PubMed ID: 16404524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Counteract Botulinum Neurotoxin A: Nature's Deadliest Biomolecule.
    Lin L; Olson ME; Eubanks LM; Janda KD
    Acc Chem Res; 2019 Aug; 52(8):2322-2331. PubMed ID: 31322847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a fluorescence internal quenching correction factor to correct botulinum neurotoxin type A endopeptidase kinetics using SNAPtide.
    Feltrup TM; Singh BR
    Anal Chem; 2012 Dec; 84(24):10549-53. PubMed ID: 23181535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
    Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
    Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
    Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir DT; Bavari S; Bowlin TL
    J Med Chem; 2010 Mar; 53(5):2264-76. PubMed ID: 20155918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
    Ambrin G; Kumar R; Singh BR
    Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high content imaging assay for identification of Botulinum neurotoxin inhibitors.
    Kota KP; Soloveva V; Wanner LM; Gomba G; Kiris E; Panchal RG; Kane CD; Bavari S
    J Vis Exp; 2014 Nov; (93):e51915. PubMed ID: 25489815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies.
    Šilhár P; Silvaggi NR; Pellett S; Čapková K; Johnson EA; Allen KN; Janda KD
    Bioorg Med Chem; 2013 Mar; 21(5):1344-8. PubMed ID: 23340139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity.
    Burnett JC; Schmidt JJ; Stafford RG; Panchal RG; Nguyen TL; Hermone AR; Vennerstrom JL; McGrath CF; Lane DJ; Sausville EA; Zaharevitz DW; Gussio R; Bavari S
    Biochem Biophys Res Commun; 2003 Oct; 310(1):84-93. PubMed ID: 14511652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of phosphoramidon and three synthetic phosphonates for inhibition of botulinum neurotoxin B catalytic activity.
    Adler M; Nicholson JD; Starks DF; Kane CT; Cornille F; Hackley BE
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S5-S11. PubMed ID: 10594892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease.
    Opsenica I; Filipovic V; Nuss JE; Gomba LM; Opsenica D; Burnett JC; Gussio R; Solaja BA; Bavari S
    Eur J Med Chem; 2012 Jul; 53():374-9. PubMed ID: 22516424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.